Crispr Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $457M | 7.1M | 64.81 |
| 2025-06-30 | $295M | 6.1M | 48.64 |
| 2025-03-31 | $89M | 2.6M | 34.03 |
| 2024-12-31 | $109M | 2.8M | 39.36 |
| 2024-09-30 | $131M | 2.8M | 46.98 |